Gilder Gagnon Howe & Co’s Merck MRK Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,525	Closed	-$112K	–	431
2021 Q1	$112K	Buy	+1,525	New	+$112K	﹤0.01%	345

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Gilder Gagnon Howe & Co's MRK Position: Q2 2021 in Review

Gilder Gagnon Howe & Co sold out of Merck (MRK) in Q2 2021, closing a stake of 1,525 shares — an estimated $112K sold.

Gilder Gagnon Howe & Co first reported a position in MRK in Q1 2021 and held it in 1 quarter. The position peaked at $112K in Q1 2021. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

Gilder Gagnon Howe & Co reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 1,525 Merck shares in Q2 2021, an estimated $112K.
Gilder Gagnon Howe & Co first reported a position in Merck in Q1 2021 and held it in 1 quarter.
Gilder Gagnon Howe & Co's Merck position peaked at $112K in Q1 2021.
2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2021, filed 16 Aug 2021.